HEADLINES
Generics lose battle against AstraZeneca’s Crestor (rosuvastatin)
posted 30/07/2010
On 30 June 2010, AstraZeneca announced that a court in the US had overruled challenges, from a number of generic producers,...
|
Regulatory recommendations for biosimilars in the EU
posted 30/07/2010
The EU has developed a general legal pathway, and the EMA ha... |
The biosimilars challenge
posted 30/07/2010
What are the challenges facing biosimilars? This was the que... |
|
|
MSD-Chibret signs generics deal with French manufacturer
posted 30/07/2010
On 25 June 2010 Merck Sharp & Dohme-Chibret (MSD-Chibret... |
Italy to scrap tender system to boost generic volumes
posted 30/07/2010
On 23 June 2010, the Italian Health Minister, Mr Ferruccio F... |
Most viewed articles
- EMEA biosimilars guidelines
- Global biosimilars guideline development – EGA’s perspective
- Top 25 biotech drugs: the next biosimilars targets?
- Safety study for subcutaneous epoetin alfa biosimilar Binocri...
- US healthcare reform passed: Biosimilars Pathway in US with 1...
- Europe is biosimilar testing ground, but US will be key market
- Teva’s hedge with generic enoxaparin versus branded glatimir
